| | Class 2 Device Recall BLOOD AGAR EMB AGAR BIPLATE |  |
| Date Initiated by Firm | February 13, 2025 |
| Date Posted | February 20, 2025 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-1201-2025 |
| Recall Event ID |
96312 |
| Product Classification |
Culture media, selective and differential - Product Code JSI
|
| Product | remel BLOOD AGAR EMB AGAR BIPLATE, REF R02041, QTY 100, for invitro diagnostic use |
| Code Information |
UDI/DI 848838003684, Lot Number 213971, exp. 2025-02-25 |
Recalling Firm/ Manufacturer |
Remel, Inc 12076 Santa Fe Trail Dr Lenexa KS 66215-3519
|
| For Additional Information Contact | Erica Knox 800-255-6730 |
Manufacturer Reason for Recall | Product may contain surface and subsurface contamination of Listeria monocytogenes which is typically visible immediately upon removal from the packaging, appearing on the blood side of the biplate. |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | Thermo Fisher Scientific issued an Urgent Medical Device Recall notice to its consignees on 02/13/2025 via US Mail. The notice explained the problem with the product, potential risk to health, and requested the following:
"Accordingly, in keeping with our Quality Policy, we request that you please notify any personnel who need to be aware of the potential for visible contamination of R02049 and R02041 and destroy any remaining inventory of lots listed above and complete the accompanying Acknowledgement form. Return the completed form indicating number of units destroyed via email to MBD.vigilance@thermofisher.com in order for your replacement/credit to be processed. Please keep this notification on file.
This notice needs to be passed on to all who need to be aware within your organization or to any organization where the potentially affected products have been transferred. If you have any questions, please contact our Technical Services Department at 800-255-6730 (US) or email microbiology.ts.us@thermofisher.com." |
| Quantity in Commerce | 316 units |
| Distribution | US Nationwide distribution. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
|
|
|